Vishank A. Shah, MBBS

Call
Website

Photos

1800 Orleans St
Baltimore, MD 21287
+1 (410) 955-5000
https://profiles.hopkinsmedicine.org
Dr. Maunank Shah is Professor of medicine at the Johns Hopkins University School of Medicine. His areas of clinical expertise include infectious disease. Dr. Shah received his undergraduate degree in biology from the University of Virginia. He earned his M.D. from the University of California, San Francisco School of Medicine. He completed his residency at Emory University School of Medicine and performed a fellowship in infectious diseases at Johns Hopkins. Dr. Shah earned his Ph.D. in clinical investigation and public health, with expertise in decision-analysis, epidemiology, and biostatistics, from the Johns Hopkins Bloomberg School of Public Health. His research interests focus on innovation in HIV and TB care. He is the inventor of video-DOT software (Scene.health) now used for patient-centered adherence support in over 700 US health departments. He is also co-inventor of HIVASSIST (www.hivassist.com), an educational and decision-support application for individualized ARV selection for persons with HIV. He has also built decision support tools for latent TB infection, and other infectious diseases. He has led WHO evidence review for novel TB diagnostics including urinary LAM antigen tests, and developed JHEEM (Johns Hopkins Epidemiologic-Economic Model), chaired the NTCA guideline development for community based TB isolation recommendations. Dr. Shah is medical director for the Baltimore City Tuberculosis Program, and past-President of the National Society of TB Clinicians. He serves on the Maryland Tuberculosis Guidelines committee and is Deputy Editor for CID, the flagship clinical journal of the Infectious Disease Society of America. An author of more than 70 peer-reviewed studies, he is a member of the International Union for TB and Lung Disease, the International AIDS Society and the Infectious Diseases Society of America. Dr. Shah leads online infectious diseases educational activities in partnership with the JH Office of Online Education, is Director of Johns Hopkins IDEAL (Center for Infectious Diseases Education, Advancement and Learning), and serves as co-director for the microbiology and infectious disease curriculum for students at the Johns Hopkins School of Medicine.

Also at this address

Owner verified
See a problem?

You might also like

Radiana Trifonova, MD
Internal medicine practitioners

Radiana Trifonova, MD

Located in Baltimore MD Dr. Dmitry Trifanov is a skilled medical professional specializing in General Medicine. With the prestigious M.D. title which stands for Doctor of Medicine in Allopathic Medicine Dr. Trifanov brings a wealth of knowledge and expertise to his practice. As a General Medical Doctor Dr. Trifanov is dedicated to providing comprehensive healthcare services to his patients. His focus on allopathic medicine ensures that he offers evidence-based treatments and care that align with modern medical practices. Patients seeking a physician who values precision and patient-centered care will find a trusted partner in Dr. Dmitry Trifanov. Generated from this place's public information
Nathan Irvin, MD

Nathan Irvin, MD

Dr. Irvin is an assistant professor in the Department of Emergency Medicine. He earned a medical degree at Harvard in 2003. Following medical school, he completed a residency in emergency medicine at Alameda Health System’s Highland Hospital in Oakland, California, where he was a chief resident, prior to graduating in 2011.Upon completion of residency, Dr. Irvin entered into the Robert Wood Johnson Foundation’s Clinical Scholars Program at the University of Pennsylvania, graduating in 2013 with a master's degree in health policy research.Dr. Irvin holds interests in social emergency medicine and addressing many of the health and behavioral problems that affect people living in urban communities. Two such threats are HIV/AIDs and violence. He is currently the clinical director of the Johns Hopkins Bayview Medical Center Emergency Department HIV/HCV screening program, working to identify and get people with new diagnoses of HIV linked into care. Additionally, he is engaged in work related to youth violence prevention and endeavors to develop a trauma-informed, hospital-based violence intervention program.
Fyza Y. Shaikh, MD

Fyza Y. Shaikh, MD

Fyza Shaikh is an Assistant Professor in Cancer Immunology in the Department of Oncology in the Sidney Kimmel Comprehensive Cancer Center. She joined the faculty after completing her fellowship in medical oncology at Johns Hopkins School of Medicine (JHSOM) and residency in internal medicine at the University of Pittsburgh Medical Center as part of the ABIM research pathway. She received her MD and PhD in Microbiology and Immunology at Vanderbilt University School of Medicine. The Shaikh lab at JHSOM is focused on how the microbiome impacts host immunological responses to tumorigenesis and anti-tumor responses to immunomodulatory agents. The lab uses a combination of translational approaches using samples collected from human cohort studies and clinical trials as well as murine models to ask more detailed mechanistic questions and works across multiple tumor types (melanoma, lung, esophageal, head and neck, etc). The overall approach uses combination of clinical, computational, and lab-based techniques using a rich biorepository containing clinically annotated metadata with known and putative biomarkers of ICI response, such as PD-L1 and tumor mutational burden, paired with longitudinal fecal and plasma samples that correlate with clinical milestones (i.e. response/nonresponse by imaging and treatment-related toxicity). The goal is to focus on microbial functionality and build defined bacterial consortia that can then be tested in murine models to define colonization, metabolomics, and intra-tumoral immune response. This translational approach, with cross-sectional and longitudinal analysis of human samples, paired with mechanistic studies in murine models, has the potential to address both limitations in previously published studies and generate new hypotheses to make advances in this field and improve ICI responses for patients with advanced malignancies.
United States›Maryland›Baltimore›Vishank A. Shah, MBBS

Yext